Clinical Trial Update: Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation

View source ↗

Summary

A completed clinical trial from NIDCD examined whether statin therapy influences hearing loss in patients with head and neck squamous cell carcinoma treated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hearing Loss
• Hyperlipidemia

Drugs mentioned

• Statin drugs (statin class (HMG-CoA reductase inhibitors))

Snippet

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) | Conditions: Head and Neck Neoplasms, Hearing Disorder | Status: COMPLETED